Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Srinivas Nalamachu completed his medical education and mandatory internship from Kakatiya Medical College Teaching Hospitals, Warangal, India. He is currently president and medical director for the International Clinical Research Institute Inc. and co-director of the Pain Management Institute in Overland Park, Kansas. In addition, Dr. Nalamachu is clinical assistant professor, Department of Rehabilitation Medicine, Kansas University Medical Center, Kansas City, Kansas, and clinical assistant professor, Department of Internal Medicine, Kansas City University of Medicine and Biosciences, Kansas City, Missouri.
He is certified by the American Board of Physical Medicine and Rehabilitation, Dr. Nalamachu is a member of the American Academy of Pain Management, American Pain Society, American Association of Electrodiagnostic Medicine, and the International Association for Study of Pain. In addition, he is on the editorial board of Pain Clinician. His is the principal investigator in numerous studies involving breakthrough, chronic pain, low back pain, and neuropathic pain. Dr. Srinivas Nalamachu has received honoraria related to formal advisory activities from Allergan, Inc. and Cephalon, Inc., and honoraria related to speakers’ bureau activities from Elan Pharmaceuticals, Inc., Pharmacia Corporation (now Pfizer Inc.), Allergan, and Cephalon. He has also received grant support related to research activities from Allergan and Endo Pharmaceuticals.
Dr. Nalamachu got involved in clinical research to help patients and to help the advancement of science. In the last 10 years, he has participated as a Principal investigator in more than 70 clinical trials and has designed a number of them. He has authored more than 25 publications and more than 60 abstracts that were presented at various national and international pain and physical medicine societies. Since 2000, Dr. Nalamachuhas lectured more than 500 times at local, regional, national and international meetings. His research is focused onbotulinum toxins, cancer pain, neuropathic pain, and abuse-deterrent opiates.
Research Article: J Pain Relief 2014, 3:163
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals